Introducing the Carmine Therapeutics Team

Image-empty-state.png

XQ Lin

Founding CEO

XQ is the Founder and Managing Partner of Esco Ventures, the corporate venture and incubation arm of Esco Group.

Image-empty-state.png

Hon-Ren Huang, Ph.D.

Senior Director of Biology

Dr. Huang received his Ph.D. from the University of Texas Southwestern Medical Center. He completed his post-doctoral training in the laboratory of Prof. Tom Maniatis at Harvard University.

Image-empty-state.png

Mark A. Kay MD, PhD

Scientific Advisor

Mark Kay is an acknowledged leader in the field of gene therapy and is a leading researcher in both viral and non-viral gene transfer vector systems.

Image-empty-state.png

Ronne Yeo, Ph.D.

Vice President, Discovery

Ronne obtained his Ph.D. in Biological Sciences from the National University of Singapore.

Image-empty-state.png

Elan Ezickson

Board Member

Elan Ezickson joined the board in 2019. He brings his extensive strategic, biopharmaceutical, operational, and capital formation expertise to Carmine Therapeutics.

Image-empty-state.png

Tenzin Gocha, Ph.D.

Director, Scientific & Business Operations

Tenzin obtained his Ph.D. in Molecular Pharmacology from New York University Medical Center.

Image-empty-state.png

Jianzhu Chen, Ph.D.

Scientific Advisor

Jianzhu Chen is a Professor of Biology at the Koch Institute for Integrative Cancer Research and at the Massachusetts Institute of Technology (MIT) Department of Biology.

© 2020 Carmine Therapeutics, Inc.

All Rights Reserved.

an

Company